[go: up one dir, main page]

DK0804176T3 - Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer - Google Patents

Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer

Info

Publication number
DK0804176T3
DK0804176T3 DK95911253T DK95911253T DK0804176T3 DK 0804176 T3 DK0804176 T3 DK 0804176T3 DK 95911253 T DK95911253 T DK 95911253T DK 95911253 T DK95911253 T DK 95911253T DK 0804176 T3 DK0804176 T3 DK 0804176T3
Authority
DK
Denmark
Prior art keywords
pct
nitroglycerin
transdermal administration
prevent unwanted
administration form
Prior art date
Application number
DK95911253T
Other languages
Danish (da)
English (en)
Inventor
Dietrich Schacht
Hans-Michael Wolff
Martin Feelisch
Adam Julian De Belder
Bruce Academic Ramsay
John Francis Martin
Christoph Christopher Lees
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Application granted granted Critical
Publication of DK0804176T3 publication Critical patent/DK0804176T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95911253T 1994-02-28 1995-02-23 Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer DK0804176T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4406332A DE4406332C1 (de) 1994-02-28 1994-02-28 Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform
PCT/EP1995/000654 WO1995022964A1 (de) 1994-02-28 1995-02-23 Transdermale darreichungsform von nitroglycerin zur verhinderung unerwünschter wehentätigkeit

Publications (1)

Publication Number Publication Date
DK0804176T3 true DK0804176T3 (da) 2001-05-28

Family

ID=6511303

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95911253T DK0804176T3 (da) 1994-02-28 1995-02-23 Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer

Country Status (15)

Country Link
US (1) US5817697A (fi)
EP (1) EP0804176B1 (fi)
JP (1) JP2823700B2 (fi)
KR (1) KR100334372B1 (fi)
CN (1) CN1069522C (fi)
AT (1) ATE200732T1 (fi)
CA (1) CA2184201A1 (fi)
DE (2) DE4406332C1 (fi)
DK (1) DK0804176T3 (fi)
ES (1) ES2156938T3 (fi)
FI (1) FI963329L (fi)
GR (1) GR3035785T3 (fi)
NO (1) NO961724L (fi)
PT (1) PT804176E (fi)
WO (1) WO1995022964A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015951A1 (en) * 2000-01-06 2002-02-07 Bader Joel S. Method of analyzing a nucleic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239318A (en) * 1983-04-27 1988-07-19 Hans R. Hoffmann Pharmaceutical product preferably in medical bandage form and process for producing them
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
KR0165875B1 (ko) * 1991-06-10 1999-01-15 . 니트로글리세린 플래스터 및 그의 제조방법
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
JPH1192367A (ja) * 1997-09-22 1999-04-06 Hoechst Marion Roussel Kk 妊娠悪阻治療剤

Also Published As

Publication number Publication date
KR100334372B1 (ko) 2002-09-04
WO1995022964A1 (de) 1995-08-31
US5817697A (en) 1998-10-06
CN1069522C (zh) 2001-08-15
DE4406332C1 (de) 1995-06-22
GR3035785T3 (en) 2001-07-31
NO961724D0 (no) 1996-04-29
EP0804176A1 (de) 1997-11-05
JP2823700B2 (ja) 1998-11-11
ATE200732T1 (de) 2001-05-15
DE59509223D1 (de) 2001-05-31
FI963329L (fi) 1996-09-05
ES2156938T3 (es) 2001-08-01
JPH09506108A (ja) 1997-06-17
KR960705553A (ko) 1996-11-08
NO961724L (no) 1996-04-29
FI963329A0 (fi) 1996-08-27
EP0804176B1 (de) 2001-04-25
CA2184201A1 (en) 1995-08-31
CN1140990A (zh) 1997-01-22
PT804176E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
DK0799209T3 (da) Sulfonamider
DE69523169D1 (de) Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
NO20015614D0 (no) Transdermalt terapeutisk system (TTS) som inneholder tolterodin
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
CA2150576A1 (fr) Compositions injectables a base de derives des taxanes
DK0557385T3 (da) Topiske sammensætninger til transdermal afgivelse af prodrug-derivater af morfin
CA2254061A1 (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
DK1063983T3 (da) Transdermalt terapeutisk system (TTS) indeholdende oxybutynin
ATE201400T1 (de) Chinazolinylamino derivate mit alfa-antagonist wirkung
ATE255895T1 (de) Zusammensetzungzur verminderung von schmerzen, die ein nicht narkotischen analgetika und ein analgetikabekräftiger enthält
ATE179164T1 (de) Hiv-proteaseinhibitoren
DK0804176T3 (da) Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer
DK0689441T3 (da) Farmaceutisk præparat i form af et kit omfattende prostaglandin E1
DK0835309T3 (da) Vaccine imod infektiøse agenser, præparat til behandling og forebyggelse af HIV infektioner
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
BE877982A (fr) Nouvelles 2-(5-pyrazolylamido)-2-imidazolines, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant
SE9001592L (sv) Terapeutisk komposition
KR910011258A (ko) 녹내장의 치료방법
FR2415622A1 (fr) Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments
KR960034171A (ko) 버들송이(Agrocybe cylindracea)로부터 생산되는 타이로시네이즈 저해 물질 및 이의 제조 방법
KR950702942A (ko) 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)
RS49717B (sr) Terapeutska injektibilna analgetska farmaceutska kompozicija nimesulida za intramuskularno davanje i postupak za njeno dobijanje